Constance
Germany
35
2021-09-16
35
2021-11-23
These are the the leading inventors for applications assigned to Takeda GmbH:
Takeda GmbH based in Constance, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Treatment of nonalcoholic fatty liver disease
#2 | 2021-04-22 ✅ Patent 11,690,839 granted on 2023-07-04Treatment of idiopathic pulmonary fibrosis
#3 | 2018-07-26 ✅ Patent 10,758,621 granted on 2020-09-01Liquid formulation comprising GM-CSF neutralizing compound
#4 | 2017-09-07 ✅ Patent 11,173,208 granted on 2021-11-16Liquid formulation comprising GM-CSF neutralizing compound
#5 | 2017-06-22 ✅ Patent 10,495,630 granted on 2019-12-03Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions
#6 | 2016-12-08 ✅ Patent 10,745,475 granted on 2020-08-18Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
#7 | 2016-09-29 ✅ Patent 9,962,377 granted on 2018-05-08Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
#8 | 2015-12-03 ✅ Patent 9,833,410 granted on 2017-12-05Lyophilized formulation comprising GM-CSF neutralizing compound
#9 | 2015-04-30 ✅ Patent 9,149,479 granted on 2015-10-06Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
#10 | 2015-03-19 ✅ Patent 9,309,187 granted on 2016-04-12EP2 receptor agonists
#11 | 2015-03-19 ✅ Patent 9,545,490 granted on 2017-01-17Apparatus for the aerosolization of large volumes of dry powder
#12 | 2014-12-25 ✅ Patent 9,090,597 granted on 2015-07-28Pyrazolone derivatives as PDE4 inhibitors
#13 | 2014-03-13 ✅ Patent 8,883,818 granted on 2014-11-11Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
#14 | 2014-02-06 ✅ Patent 8,829,189 granted on 2014-09-09Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
#15 | 2013-09-05 ✅ Patent 8,618,142 granted on 2013-12-31Process for the preparation of roflumilast
#16 | 2013-08-29 ✅ Patent 8,604,064 granted on 2013-12-10Process for the preparation of roflumilast
#17 | 2013-04-18 ✅ Patent 8,754,218 granted on 2014-06-17Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
#18 | 2013-01-10 ✅ Patent 8,865,745 granted on 2014-10-21Pyrazolone derivatives as PDE4 inhibitors
#19 | 2012-11-15 ✅ Patent 9,018,175 granted on 2015-04-283,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives
#20 | 2012-10-04 ✅ Patent 8,440,210 granted on 2013-05-14Stabilized pharmaceutical product
#21 | 2012-04-19 ✅ Patent 8,910,627 granted on 2014-12-16Apparatus for the aerosolization of large volumes of dry powder
#22 | 2011-11-03 ✅ Patent 8,541,456 granted on 2013-09-24Roflumilast for the treatment of diabetes mellitus type 2
#23 | 2011-10-13 ✅ Patent 8,431,154 granted on 2013-04-30Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
#24 | 2011-09-08 ✅ Patent 8,609,848 granted on 2013-12-17Pyrazolone-derivatives and their use as PDE-4 inhibitors
#25 | 2011-07-14 ✅ Patent 8,758,817 granted on 2014-06-24Dosage form containing (S)-pantoprazole as active ingredient
#26 | 2011-04-21 ✅ Patent 8,486,923 granted on 2013-07-16Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
#27 | 2011-01-27 ✅ Patent 8,445,501 granted on 2013-05-21Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines
#28 | 2010-01-14 ✅ Patent 8,481,516 granted on 2013-07-09Ciclesonide containing sterile aqueous suspension
#29 | 2009-08-20 ✅ Patent 8,703,192 granted on 2014-04-22Dosage form containing pantoprazole as active ingredient
#30 | 2009-04-09 ✅ Patent 8,754,108 granted on 2014-06-17Freeze-dried pantoprazole preparation and pantoprazole injection
#31 | 2008-09-18 ✅ Patent 8,465,767 granted on 2013-06-18Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
#32 | 2007-11-08 ✅ Patent 9,205,044 granted on 2015-12-08Aqueous pharmaceutical preparation comprising roflumilast
#33 | 2007-02-01 ✅ Patent 8,464,707 granted on 2013-06-18Compliance monitor and method
#34 | 2006-06-15 ✅ Patent 9,422,327 granted on 2016-08-23Process for preparing crystalline ciclesonide with defined particle size
#35 | 2006-06-15 ✅ Patent 8,435,497 granted on 2013-05-07Formoterol of and ciclesonide combination
Also check out Takeda GmbH's (Constance, Germany) applicant profile with 20 patent applications submitted.
464716 ⎘